Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Evidence released in the Lancet demonstrates a link between patient age and risk of revision on knee and hip replacements.

Researchers at NDORMS, University of Oxford have examined data from over 100,000 patients who have previously undergone joint replacements to enable prediction of the likelihood of requiring surgical revision of the joint.

There are an increasing number of patients undergoing total knee and hip joint replacements every year. These have proven beneficial to patients, but with replacement comes the risk that the joint might require subsequent surgical revision which, in turn, can lead to less favourable outcomes.

Their study has shown that while the lifetime risk of joints requiring revision is around 5% in patients who receive joint replacements at aged 70 or above, for men in their early fifties this can rise to over a third. Presenting risk information in this way can allow patients, particularly younger patients, to make more informed decisions about if and when to opt for joint replacement surgery.

Lead Investigator Professor Andrew Price, Prof of Musculoskeletal Sciences at NDORMS confirmed "This work is of great importance for all patients who are considering whether to undergo a joint replacement. It is critical that they have the best information available to make informed decisions and we believe this work is a significant contribution to achieve this goal".

To read the full paper entitled "The effect of Patient Age at Intervention on Risk of Implant Revision after Total Replacement of the Hip or Knee: A population=based cohort study" can be read here.

Similar stories

Ten Years of Athena Swan in the Medical Sciences Division

2022 marks ten years since the first Athena Swan Bronze applications from the Medical Sciences Division. Ten years later, and all 16 departments in the Division have achieved a Silver Award. We look at NDORMS’ Athena Swan journey.

NDORMS researchers awarded Associate Professor title

The University of Oxford has awarded the title of Associate Professor to Adam Cribbs and Luke Jostins.

Oxford's largest ever study into varicose veins shows need for surgery is linked to genetics

A new international study by Oxford researchers published in Nature Communications, establishes for the first time a critical genetic risk score to predict the likelihood of patients suffering with varicose veins to require surgery, as well as pointing the way towards potential new therapies.

Reflecting on the role of Clinical Director of Trauma and Orthopaedics

In 2021 Professor Andrew Price was appointed Clinical Director of Trauma and Orthopaedics at the Oxford University Hospitals NHS Foundation Trust. After 9 months in post, we find out what the challenges are and what he’s been able to bring to the role.

Building a humanoid bioreactor

A humanoid robot is being used at NDORMS in an attempt to grow tendon tissue for repairing shoulder injuries.

Professor Fiona Powrie recognised in Queen’s Birthday Honours

Professor Fiona Powrie was honoured in the 2022 Queen’s Birthday Honours List, published as Her Majesty celebrates her Platinum Jubilee.